Cancer

Seres Therapeutics to Participate in Piper Sandler Healthcare Conference

CAMBRIDGE, Mass., Nov. 22, 2024 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading live biotherapeutics company, today announced…

18 hours ago

Orion Research Foundation grants EUR 1,109,000 for research in 2025

Orion Research Foundation grants EUR 1,109,000 for research in 2025 Press release 22 November, 2024 at 9.00 EET Orion Research…

18 hours ago

HUTCHMED Announces Launch by Takeda of FRUZAQLA® (fruquintinib) in Japan

— Launch follows approval by Japanese Ministry of Health, Labour and Welfare in September 2024 — — Milestone payment to be made to…

18 hours ago

Hemogenyx Pharmaceuticals PLC Announces IRB Approval for Phase I Clinical Trial

Hemogenyx Pharmaceuticals Receives IRB Approval for Phase 1 Clinical Trial of HEMO-CAR-T (HG-CT-1)LONDON, UK / ACCESSWIRE / November 22, 2024…

1 day ago

United Imaging Announces the First of Several New U.S. Product Launches For RSNA

The first uMI Panvivo in the world lands at the growing Pueblo Medical Imaging in Nevada. HOUSTON, Nov. 21, 2024…

1 day ago

Brooks Rehabilitation, Nemours Children’s Health, Wolfson Children’s Hospital and UF Health Jacksonville Partner to Enhance Pediatric Care

JACKSONVILLE, Fla., Nov. 21, 2024 /PRNewswire/ -- By combining resources and expertise, Brooks Rehabilitation, Nemours Children's Health, Jacksonville, Wolfson Children's…

1 day ago

ImmunityBio and nCartes Enter Collaboration Agreement on Clinical Trial Data Fulfillment

FREMONT, Calif., Nov. 21, 2024 /PRNewswire/ -- ImmunityBio, Inc. (NASDAQ: IBRX), a vertically integrated biotechnology company, and nCartes, Inc., a…

2 days ago

Breakthrough Genomics Joins Forces with the PRECEDE Consortium to Help Accelerate the Early Detection of Pancreatic Cancer

SAN DIEGO, Nov. 21, 2024 /PRNewswire/ -- Breakthrough Genomics, a leader in the clinical analysis of genomic data and early cancer…

2 days ago

Outcomes4Me and the National Comprehensive Cancer Network (NCCN) Expand Collaboration to Improve Outcomes for Patients Diagnosed with Prostate Cancer

Enhanced integration fuels the rapid growth of this first-of-its kind platform and related initiative between Outcomes4Me and NCCN, leveraging technology to…

2 days ago

Gaining Momentum, Biodexa is Advancing Two Recent Acquisitions Through the Clinic

CARDIFF, UK / ACCESSWIRE / November 21, 2024 / Biodexa Pharmaceuticals PLC (NASDAQ:BDRX), an acquisition-focused clinical-stage biopharmaceutical company focused on…

2 days ago